Coronary artery diseases and particularly acute myocardial infarction are the leading causes
of mortality and morbidity in western countries. Despite the achievements of the last decades …

Predictors and outcomes of no-reflow phenomenon in patients... : Coronary Artery Disease
Predictors and outcomes of no-reflow phenomenon in patients with acute ST-segment elevation …

Background: The no-reflow phenomenon is an uncommon and critical occurrence which
myocardial reperfusion does not restore to its optimal level. Several predisposing factors of …

Background: Occurrence of no reflow phenomenon during percutaneous coronary
intervention (PCI) is associated with increased mortality. Although intracoronary medications …

The lack of reperfusion of myocardium after prolonged ischaemia that may occur despite
opening of the infarct-related artery is termed “no reflow”. No reflow or slow flow occurs in 3 …

No-reflow is responsible for 40% of the primary percutaneous coronary intervention without
complete myocardial reperfusion despite successful reopening of the infarct-related artery …

Prediction of no-reflow phenomenon in patients treated with... : Medicine Prediction of no-reflow
phenomenon in patients treated with primary percutaneous coronary intervention for ST-segment …

No-reflow during percutaneous coronary intervention (PCI) is observed most commonly
during saphenous vein graft intervention, rotational atherectomy and primary PCI for acute …

Background: No‐reflow (NR) phenomenon is a well‐known problem, often accompanying
percutaneous coronary intervention for acute ST elevation myocardial infarction (STEMI) …

Previous studies describing the no-reflow phenomenon in patients with acute myocardial
infarction (AMI) undergoing percutaneous coronary intervention (PCI) were largely confined …